Cochlear Gets New Bull Despite Potential 1H Earnings Miss -- Market Talk

Dow Jones

01/19

2340 GMT - Hearing implant maker Cochlear gets a new bull in RBC Capital Markets despite it warning of potential disappointment at its upcoming 1H result. RBC upgrades Cochlear to outperform, from sector perform, and raises its price target by 10% to A$325.00/share. "We believe Cochlear could miss consensus forecasts due to weaker than expected performance in CI and Services," says analyst Craig Wong-Pan. RBC forecasts 1H revenue of A$1.19 billion, slightly below consensus estimates of A$1.22 billion. It thinks net profit will fall short of expectations, projecting A$196 million versus a market forecast of A$205 million. Still, it thinks management will keep annual underlying profit guidance of A$435 million-A$460 million intact, albeit with a pronounced 2H skew due partly to the timing of the Nucleus Nexa implant system launch. (david.winning@wsj.com; @dwinningWSJ)

(END) Dow Jones Newswires

January 18, 2026 18:40 ET (23:40 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2604970907"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2604970907\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2604970907?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-19 07:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2604970907","market":"nz","top_or_hot":-1,"title":"Cochlear Gets New Bull Despite Potential 1H Earnings Miss -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     2340 GMT - Hearing implant maker Cochlear gets a new bull in RBC Capital Markets despite it warning of potential disappointment at its upcoming 1H result. RBC upgrades Cochlear to outperform, from sector perform, and raises its price target by 10% to A$325.00/share. \"We believe Cochlear could miss consensus forecasts due to weaker than expected performance in CI and Services,\" says analyst Craig Wong-Pan. RBC forecasts 1H revenue of A$1.19 billion, slightly below consensus estimates of A$1.22 billion. It thinks net profit will fall short of expectations, projecting A$196 million versus a market forecast of A$205 million. Still, it thinks management will keep annual underlying profit guidance of A$435 million-A$460 million intact, albeit with a pronounced 2H skew due partly to the timing of the Nucleus Nexa implant system launch. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 18, 2026 18:40 ET (23:40 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cochlear Gets New Bull Despite Potential 1H Earnings Miss -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCochlear Gets New Bull Despite Potential 1H Earnings Miss -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-19 07:40</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     2340 GMT - Hearing implant maker Cochlear gets a new bull in RBC Capital Markets despite it warning of potential disappointment at its upcoming 1H result. RBC upgrades Cochlear to outperform, from sector perform, and raises its price target by 10% to A$325.00/share. \"We believe Cochlear could miss consensus forecasts due to weaker than expected performance in CI and Services,\" says analyst Craig Wong-Pan. RBC forecasts 1H revenue of A$1.19 billion, slightly below consensus estimates of A$1.22 billion. It thinks net profit will fall short of expectations, projecting A$196 million versus a market forecast of A$205 million. Still, it thinks management will keep annual underlying profit guidance of A$435 million-A$460 million intact, albeit with a pronounced 2H skew due partly to the timing of the Nucleus Nexa implant system launch. (david.winning@wsj.com; @dwinningWSJ) \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 18, 2026 18:40 ET (23:40 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"COH.AU","symbol_name":"COCHLEAR LTD","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2604970907","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2604970907","pubTimestamp":1768779600,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"2340 GMT - Hearing implant maker Cochlear gets a new bull in RBC Capital Markets despite it warning of potential disappointment at its upcoming 1H result. RBC upgrades Cochlear to outperform, from sector perform, and raises its price target by 10% to A$325.00/share. \"We believe Cochlear could miss consensus forecasts due to weaker than expected performance in CI and Services,\" says analyst Craig Wong-Pan. RBC forecasts 1H revenue of A$1.19 billion, slightly below consensus estimates of A$1.22 billion. It thinks net profit will fall short of expectations, projecting A$196 million versus a market forecast of A$205 million. Still, it thinks management will keep annual underlying profit guidance of A$435 million-A$460 million intact, albeit with a pronounced 2H skew due partly to the timing of the Nucleus Nexa implant system launch. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"COH.AU":"COCHLEAR LTD","BK7007":"医疗保健设备"},"translate_title":"尽管上半年盈利可能低于预期，科利耳仍获得新的牛市——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"COH.AU":0.9},"content_text":"2340 GMT - Hearing implant maker Cochlear gets a new bull in RBC Capital Markets despite it warning of potential disappointment at its upcoming 1H result. RBC upgrades Cochlear to outperform, from sector perform, and raises its price target by 10% to A$325.00/share. \"We believe Cochlear could miss consensus forecasts due to weaker than expected performance in CI and Services,\" says analyst Craig Wong-Pan. RBC forecasts 1H revenue of A$1.19 billion, slightly below consensus estimates of A$1.22 billion. It thinks net profit will fall short of expectations, projecting A$196 million versus a market forecast of A$205 million. Still, it thinks management will keep annual underlying profit guidance of A$435 million-A$460 million intact, albeit with a pronounced 2H skew due partly to the timing of the Nucleus Nexa implant system launch. (david.winning@wsj.com; @dwinningWSJ) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 18, 2026 18:40 ET (23:40 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}